Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.05 CNY
1.60 B CNY
11.54 B CNY
742.83 M
About PHARMARON BEIJING
Sector
CEO
Bo Liang Lou
Website
Headquarters
Beijing
Founded
2004
ISIN
CNE100003JW4
FIGI
BBG00H2R0YL2
Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services. The company was founded by Bo Liang Lou, Xiao Qiang Lou and Bei Zheng on July 1, 2004 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300759 is 30.55 CNY — it has decreased by −1.23% in the past 24 hours. Watch PHARMARON BEIJING stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange PHARMARON BEIJING stocks are traded under the ticker 300759.
300759 stock has risen by 5.71% compared to the previous week, the month change is a −11.09% fall, over the last year PHARMARON BEIJING has showed a −13.94% decrease.
We've gathered analysts' opinions on PHARMARON BEIJING future price: according to them, 300759 price has a max estimate of 38.00 CNY and a min estimate of 8.20 CNY. Watch 300759 chart and read a more detailed PHARMARON BEIJING stock forecast: see what analysts think of PHARMARON BEIJING and suggest that you do with its stocks.
300759 reached its all-time high on Aug 5, 2021 with the price of 108.71 CNY, and its all-time low was 4.08 CNY and was reached on Jan 28, 2019. View more price dynamics on 300759 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300759 stock is 4.23% volatile and has beta coefficient of 1.54. Track PHARMARON BEIJING stock price on the chart and check out the list of the most volatile stocks — is PHARMARON BEIJING there?
Today PHARMARON BEIJING has the market capitalization of 55.45 B, it has increased by 3.82% over the last week.
Yes, you can track PHARMARON BEIJING financials in yearly and quarterly reports right on TradingView.
PHARMARON BEIJING is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
300759 earnings for the last quarter are 0.17 CNY per share, whereas the estimation was 0.23 CNY resulting in a −23.06% surprise. The estimated earnings for the next quarter are 0.33 CNY per share. See more details about PHARMARON BEIJING earnings.
PHARMARON BEIJING revenue for the last quarter amounts to 3.21 B CNY, despite the estimated figure of 3.38 B CNY. In the next quarter, revenue is expected to reach 3.34 B CNY.
300759 net income for the last quarter is 308.40 M CNY, while the quarter before that showed 882.85 M CNY of net income which accounts for −65.07% change. Track more PHARMARON BEIJING financial stats to get the full picture.
Yes, 300759 dividends are paid annually. The last dividend per share was 0.20 CNY. As of today, Dividend Yield (TTM)% is 0.65%. Tracking PHARMARON BEIJING dividends might help you take more informed decisions.
PHARMARON BEIJING dividend yield was 0.69% in 2023, and payout ratio reached 22.03%. The year before the numbers were 0.42% and 24.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 20.30 K employees. See our rating of the largest employees — is PHARMARON BEIJING on this list?
Like other stocks, 300759 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARON BEIJING stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARON BEIJING technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARON BEIJING stock shows the neutral signal. See more of PHARMARON BEIJING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.